OC5:FRA
Cochlear Ltd
€88.04
arrow_upward
+2.73%(+2.34) 1D
Sep 4, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OC5...
Open
€88.04
High
€88.04
Low
€88.04
Mkt. cap
9.34B
Avg. vol.
16.00
Volume
0.00
52-wk high
€171.76
52-wk low
€55.17
No. of employees
5K
Open
€88.04
High
€88.04
Low
€88.04
Mkt. cap
9.34B
Avg. vol.
16.00
Volume
0.00
52-wk high
€171.76
52-wk low
€55.17
No. of employees
5K
News stories
From web sources and news partners
TipRanks
·
2 days ago
Cochlear Dropped from S&P/ASX 50 in September Index Rebalance
TipRanks
·
2 days ago
Citi Group Entities Exit Substantial Holder Status in Cochlear
Simply Wall Street
·
2 days ago
Cochlear And 2 Other Australian Undervalued Stocks
Profile
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
About Cochlear Ltd
CEODig Howitt
Employees5.4K
Founded1981
HeadquartersSydney, New South Wales, Australia
SectorMedical device
Websitecochlear.com